CRVL Q1 2026 Earnings EPS of 061 Exceeds Expectation Stock Declines 269 American Strategic Investment Co Q1 2026 Earnings Widened Loss Amidst Portfolio Realignment Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage PMV Pharmaceuticals PMVP Q1 2026 Earnings Narrower Loss Provides a Glimmer of Operational Efficiency MOLN Q4 2025 Earnings Positive EPS Surprise Highlights Cost Discipline Amid Clinical Progress THRY Q1 2026 Earnings Stellar EPS Beat Drives Stock Surge